Neuropathic PainQuality-of-Life Impact, Costs and Cost Effectiveness of Therapy

被引:0
|
作者
Alec B. O’Connor
机构
[1] University of Rochester School of Medicine and Dentistry,Department of Medicine
来源
PharmacoEconomics | 2009年 / 27卷
关键词
Neuropathic Pain; Gabapentin; Herpes Zoster; Carpal Tunnel Syndrome; Pregabalin;
D O I
暂无
中图分类号
学科分类号
摘要
A number of different diseases or injuries can damage the central or peripheral nervous system and produce neuropathic pain (NP), which seems to be more difficult to treat than many other types of chronic pain. As a group, patients with NP have greater medical co-morbidity burden than age- and sex-adjusted controls, which makes determining the humanistic and economic burden attributable to NP challenging.
引用
收藏
页码:95 / 112
页数:17
相关论文
共 50 条
  • [1] Neuropathic Pain Quality-of-Life Impact, Costs and Cost Effectiveness of Therapy
    O'Connor, Alec B.
    [J]. PHARMACOECONOMICS, 2009, 27 (02) : 95 - 112
  • [2] The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
    I M C M de Kok
    J J Polder
    J D F Habbema
    L-M Berkers
    W J Meerding
    M Rebolj
    M van Ballegooijen
    [J]. British Journal of Cancer, 2009, 100 : 1240 - 1244
  • [3] The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
    de Kok, I. M. C. M.
    Polder, J. J.
    Habbema, J. D. F.
    Berkers, L-M
    Meerding, W. J.
    Rebolj, M.
    van Ballegooijen, M.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (08) : 1240 - 1244
  • [4] Costs and cost-effectiveness of colorectal cancer prevention and therapy
    Schrag, D
    Weeks, J
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 561 - 568
  • [5] The Cost-Effectiveness of Sleep Apnea Management: A Critical Evaluation of the Impact of Therapy on Health Care Costs
    Pendharkar, Sachin R.
    Kaambwa, Billingsley
    Kapur, Vishesh K.
    [J]. CHEST, 2024, 166 (03) : 612 - 621
  • [6] A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness
    Gandjour, Afschin
    Stock, Stephanie
    [J]. HEALTH POLICY, 2007, 83 (2-3) : 257 - 267
  • [7] COSTS AND COST-EFFECTIVENESS
    GOLDMAN, M
    [J]. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 1994, 76 (03) : 213 - 214
  • [8] Cost-effectiveness - Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging measures: A comparison of five European countries
    Voelkel, Lukas
    [J]. GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2023, 28 (06): : 265 - 266
  • [9] Cost-Effectiveness of Cancer Screening: Health and Costs in Life Years Gained
    Ratushnyak, Svetlana
    Hoogendoorn, Martine
    van Baal, Pieter H. M.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2019, 57 (06) : 792 - 799
  • [10] Controlling Healthcare Costs Just Cost Effectiveness or "Just" Cost Effectiveness?
    Fleck, Leonard M.
    [J]. CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 2018, 27 (02) : 271 - 283